Chemotherapy for pulmonary tuberculosis. A short-course regimen and its rationale.
After years of declining incidence, pulmonary tuberculosis is increasing, owing in part to the influx of Asian refugees. An understanding of the tubercle bacillus and a knowledge of chemotherapy enable the physician to give adequate treatment. Short-course chemotherapy has been found to be 99% effective in clinical trials, leading the American Thoracic Society to recommend use of this mode of treatment.